Related Experiment Video
Updated: May 23, 2026
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Evaluation of the EndoPAT as a Tool to Assess Endothelial Function
M Moerland1, A J Kales, L Schrier
1Centre for Human Drug Research, Department of Vascular Medicine, Zernikefdreef 10, 2333 CL Leiden, The Netherlands.
International Journal of Vascular Medicine
|April 14, 2012
Summary
The EndoPAT device showed stable endothelial function measurements in renally impaired patients. However, it did not detect changes from interventions in healthy volunteers, questioning its use in early drug development.
Area of Science:
- Cardiovascular Research
- Medical Device Technology
- Clinical Pharmacology
Background:
- Endothelial dysfunction is a key factor in systemic diseases, making it a target for pharmaceutical interventions.
- Noninvasive methods for assessing endothelial function are crucial for evaluating treatment efficacy.
- The EndoPAT device offers a noninvasive approach to measure endothelial function.
Purpose of the Study:
- To assess the feasibility and discriminating power of the EndoPAT for evaluating acute changes in endothelial function.
- To investigate the stability of endothelial function measurements over time in specific patient populations.
- To determine the EndoPAT's sensitivity to detect effects of interventions on endothelial function.
Main Methods:
- Repeated noninvasive measurements of endothelial function using the EndoPAT device.
- Assessment of measurement stability (coefficient of variation) in renally impaired patients.
- Comparison of endothelial function between renally impaired, type 2 diabetic patients, and healthy volunteers.
- Evaluation of EndoPAT's response to acute interventions (glucose load, smoking) in healthy volunteers.
Main Results:
- Endothelial function measurements by EndoPAT demonstrated stability over time in renally impaired patients (CV 13%).
- No significant decrease in endothelial function was observed in renally impaired or type 2 diabetic patients compared to healthy volunteers.
- The EndoPAT failed to detect significant changes in endothelial function following glucose load or smoking in healthy volunteers.
Conclusions:
- The EndoPAT shows promise for stable endothelial function assessment in certain populations but lacks sensitivity for detecting acute changes in early-phase studies.
- Further research is needed to validate EndoPAT against conventional methods and establish its utility in drug development and clinical practice.
- Physiological differences in endothelial function measurement between EndoPAT and conventional techniques require careful investigation.
